The patient received prior treatment with gemcitabine, cisplatin and nab-paclitaxel and, at progression, FGFR2 p.C382R mutation was detected in the tumor tissue and blood sample by sequencing analysis37,38. The gene discussed is FGFR2; the disease is neoplasm.